Molecularly, right-sided primary tumor-derived MSS-type mCRC has a higher median TMB, with oncogenic alterations like KRAS, BRAF, and PIK3CA enriched, while APC and TP53 are more enriched in left-sided tumors (54). This evidence concerns the gene BRAF and neoplasm.